论文部分内容阅读
目的:评价盐酸氨溴索注射液雾化吸入治疗小儿肺炎的临床效果。方法:选择2015年12月-2016年11月我院收治的小儿肺炎患者80例作为研究对象,采用随机信封法将其分为对照组(n=40)和实验组(n=40),对照组采用常规治疗;实验组采用盐酸氨溴索注射液雾化吸入治疗,对比分析两组患者临床症状缓解时间、不良反应发生率。结果:实验组临床症状缓解时间、不良反应发生率明显低于对照组,P<0.05。结论:在小儿肺炎临床治疗中,采用盐酸氨溴索注射液雾化吸入治疗,即可减少临床症状缓解时间,又可减少不良反应发生率,值得临床推广应用。
Objective: To evaluate the clinical effect of inhalation of ambroxol hydrochloride in children with pneumonia. Methods: Totally 80 children with pneumonia admitted from December 2015 to November 2016 in our hospital were selected as research objects, and randomly divided into control group (n = 40) and experimental group (n = 40) The rats in the experimental group were treated with Ambroxol Hydrochloride Injection by inhalation, and the clinical symptom relief time and the incidence of adverse reactions were compared between the two groups. Results: The clinical symptom relief time and the incidence of adverse reactions in the experimental group were significantly lower than those in the control group (P <0.05). Conclusion: In the clinical treatment of children with pneumonia, the use of ambroxol hydrochloride injection inhalation therapy can reduce the clinical symptoms of remission time, but also reduce the incidence of adverse reactions, it is worth promoting the clinical application.